OptiNose
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch OptiNose and buy or sell other stocks, ETFs, and their options commission-free!About OPTN
OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists.
CEOEvan Loh, MD
CEOEvan Loh, MD
Employees128
Employees128
HeadquartersYardley, Pennsylvania
HeadquartersYardley, Pennsylvania
Founded2000
Founded2000
Employees128
Employees128
OPTN Key Statistics
Market cap97.22M
Market cap97.22M
Price-Earnings ratio-3.22
Price-Earnings ratio-3.22
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$20.03
52 Week high$20.03
52 Week low$4.82
52 Week low$4.82
Stock Snapshot
As of today, OptiNose(OPTN) shares are valued at $9.60. The company's market cap stands at 97.22M, with a P/E ratio of -3.22.
During the trading day, OptiNose(OPTN) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0.
The stock's 52-week range extends from a low of $4.82 to a high of $20.03.
The stock's 52-week range extends from a low of $4.82 to a high of $20.03.
People also own
Based on the portfolios of people who own OPTN. This list is generated using Robinhood data, and it’s not a recommendation.